About Haemonetics
Haemonetics is a company based in Braintree (United States) founded in 1971.. The company has 3,020 employees as of March 31, 2024. Haemonetics has completed 9 acquisitions, including Arryx, Attune Medical and Cardival Medical. Haemonetics offers products and services including Plasma Collection Systems, BloodTrack Software, and SafeTrace Tx. Haemonetics operates in a competitive market with competitors including VISIE, Vetex Medical, MediSieve, Sisu Global Health and Immutrix Therapeutics, among others.
- Headquarter Braintree, United States
- Employees 3020 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Haemonetics Corporation
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Haemonetics
Haemonetics is a publicly listed company on the NYSE with ticker symbol HAE in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Haemonetics
Haemonetics offers a comprehensive portfolio of products and services, including Plasma Collection Systems, BloodTrack Software, and SafeTrace Tx. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Tools for efficient plasma yield and donor experience enhancement.
Platform for blood inventory and safety management.
Software for blood center operations and traceability.
Unlock access to complete
Unlock access to complete
Software Development Team
125 people
Senior Team
37 people
Leadership Team
36 people
Sales and Marketing
24 people
Product Management Team
22 people
Legal and Compliance
15 people
Finance and Accounting
15 people
Human Resources and Administration
13 people
Unlock access to complete
Funding Insights of Haemonetics
- Total Funding Total Funding
- Total Rounds 3
- Last Round Grant — $3.8M
-
First Round
First Round
(01 Jan 2012)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2021 | Amount | Grant - Haemonetics | Valuation |
investors |
|
| Mar, 2021 | Amount | Post-IPO - Haemonetics | Valuation |
investors |
|
| Jan, 2012 | Amount | Grant - Haemonetics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Haemonetics
Haemonetics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Haemonetics
Haemonetics has strategically engaged in corporate development activities, having acquired 9 companies. Notable acquisitions include Arryx, Attune Medical and Cardival Medical. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of device for coagulation diagnostic
|
2017 | ||||
|
Patient temperature is modulated via esophageal cooling devices.
|
2009 | ||||
|
Bioabsorbable implants and delivery systems for arteriotomy closure are developed.
|
2009 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Haemonetics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Haemonetics Comparisons
Competitors of Haemonetics
Haemonetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as VISIE, Vetex Medical, MediSieve, Sisu Global Health and Immutrix Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of 3D intraoperative imaging technology for orthopedic, neuro, and spine surgery
|
|
| domain | founded_year | HQ Location |
Catheters for venous clot management and removal are developed.
|
|
| domain | founded_year | HQ Location |
Magnetic therapy is developed to treat blood-borne diseases.
|
|
| domain | founded_year | HQ Location |
Intraoperative autotransfusion devices are developed and provided.
|
|
| domain | founded_year | HQ Location |
Blood cleansing treatment device
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Haemonetics
Frequently Asked Questions about Haemonetics
When was Haemonetics founded?
Haemonetics was founded in 1971 and raised its 1st funding round 41 years after it was founded.
Where is Haemonetics located?
Haemonetics is headquartered in Braintree, United States. It is registered at Braintree, Massachusetts, United States.
Who is the current CEO of Haemonetics?
Chris Simon is the current CEO of Haemonetics.
How many employees does Haemonetics have?
As of Mar 31, 2024, the latest employee count at Haemonetics is 3,020.
What is the annual revenue of Haemonetics?
Annual revenue of Haemonetics is $1.36B as on Mar 31, 2024.
What does Haemonetics do?
Haemonetics was founded in 1971 and is based in Braintree, United States. Operations focus on the hematology sector within the medical industry, where products and solutions are developed for blood management and related procedures. Offerings include SafeTrace for transfusion tracking in blood banks, Persona as a plasma collection system integrated with the NexSys PCS platform, and VASCADE for arterial and venous closure to limit risks in interventions.
Who are the top competitors of Haemonetics?
Haemonetics's top competitors include VISIE, Vetex Medical and Sisu Global Health.
What products or services does Haemonetics offer?
Haemonetics offers Plasma Collection Systems, BloodTrack Software, and SafeTrace Tx.
Is Haemonetics publicly traded?
Yes, Haemonetics is publicly traded on NYSE under the ticker symbol HAE.
How many acquisitions has Haemonetics made?
Haemonetics has made 9 acquisitions, including Arryx, Attune Medical, and Cardival Medical.
Who are Haemonetics's investors?
Haemonetics has 1 investor. Key investors include HHS.
What is Haemonetics's ticker symbol?
The ticker symbol of Haemonetics is HAE on NYSE.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.